The Role of High Triglycerides Level in Predicting Cognitive Impairment: A Review of Current Evidence

Overview

Journal Nutrients

Date 2021 Jul 2

PMID 34203094

Citations 27

Authors

Alina Mihaela Dimache

Delia Lidia Salaru

Radu Sascau

Cristian Statescu

Affiliations

Soon will be listed here.

Abstract

The burden of cognitive disorders is huge and still growing, however the etiology and the degree of cognitive impairment vary considerably. Neurodegenerative and vascular mechanisms were most frequently assessed in patients with dementia. Recent studies have shown the possible involvement of triglycerides levels in cognitive function through putative mechanisms such as brain blood barrier dysfunction or amyloid metabolism imbalance, but not all research in the field found this association. Several clinical studies evaluated the relationship between different forms of cognitive decline and levels of serum triglycerides, independent of other cardiovascular risk factors. This review focuses on the role of triglycerides in cognitive decline, cerebral amyloidosis and vascular impairment. Considering that the management of hypertriglyceridemia benefits from lifestyle modification, diet, and specific drug therapy, future studies are requested to appraise the triglycerides-cognitive impairment relationship.

Citing Articles

Consuming a modified Mediterranean ketogenic diet reverses the peripheral lipid signature of Alzheimer's disease in humans.

Neth B, Huynh K, Giles C, Wang T, Mellett N, Duong T Commun Med (Lond). 2025; 5(1):11.

PMID: 39779882 PMC: 11711287. DOI: 10.1038/s43856-024-00682-w.

Circadian Influences on Brain Lipid Metabolism and Neurodegenerative Diseases.

Hussain Y, Dar M, Pan X Metabolites. 2024; 14(12).

PMID: 39728504 PMC: 11677446. DOI: 10.3390/metabo14120723.

The Association Between Inflammatory Dietary Pattern and Risk of Cognitive Impairment Among Older Adults with Chronic Diseases and Its Multimorbidity: A Cross-Sectional Study.

Wang L, Cheng L, Lv C, Kou J, Feng W, Xie H Clin Interv Aging. 2024; 19:1685-1701.

PMID: 39421014 PMC: 11484775. DOI: 10.2147/CIA.S474907.

Metabolomic and Lipidomic Analysis of Manganese-Associated Parkinsonism: a Case-Control Study in Brescia, Italy.

Lewis F, Shoieb D, Azmoun S, Colicino E, Jin Y, Chi J medRxiv. 2024; .

PMID: 39281765 PMC: 11398432. DOI: 10.1101/2024.09.04.24313002.

Primary care biomarkers and dementia in people of the Torres Strait, Australia: extended data analysis.

Thompson F, Russell S, Quigley R, McDonald M, Sagigi B, Taylor S Front Dement. 2024; 2:1218709.

PMID: 39081976 PMC: 11285673. DOI: 10.3389/frdem.2023.1218709.

References

He Q, Li Q, Zhao J, Wu T, Ji L, Huang G . Relationship between plasma lipids and mild cognitive impairment in the elderly Chinese: a case-control study. Lipids Health Dis. 2016; 15(1):146. PMC: 5011904. DOI: 10.1186/s12944-016-0320-6. View

Sampson U, Fazio S, Linton M . Residual cardiovascular risk despite optimal LDL cholesterol reduction with statins: the evidence, etiology, and therapeutic challenges. Curr Atheroscler Rep. 2011; 14(1):1-10. PMC: 3697085. DOI: 10.1007/s11883-011-0219-7. View

Proitsi P, Kim M, Whiley L, Simmons A, Sattlecker M, Velayudhan L . Association of blood lipids with Alzheimer's disease: A comprehensive lipidomics analysis. Alzheimers Dement. 2016; 13(2):140-151. DOI: 10.1016/j.jalz.2016.08.003. View

Raffaitin C, Gin H, Empana J, Helmer C, Berr C, Tzourio C . Metabolic syndrome and risk for incident Alzheimer's disease or vascular dementia: the Three-City Study. Diabetes Care. 2008; 32(1):169-74. PMC: 2606808. DOI: 10.2337/dc08-0272. View

Solfrizzi V, Scafato E, Capurso C, DIntrono A, Colacicco A, Frisardi V . Metabolic syndrome and the risk of vascular dementia: the Italian Longitudinal Study on Ageing. J Neurol Neurosurg Psychiatry. 2009; 81(4):433-40. DOI: 10.1136/jnnp.2009.181743. View

Nagga K, Gustavsson A, Stomrud E, Lindqvist D, van Westen D, Blennow K . Increased midlife triglycerides predict brain β-amyloid and tau pathology 20 years later. Neurology. 2017; 90(1):e73-e81. PMC: 5754649. DOI: 10.1212/WNL.0000000000004749. View

Vanhanen M, Koivisto K, Moilanen L, Helkala E, Hanninen T, Soininen H . Association of metabolic syndrome with Alzheimer disease: a population-based study. Neurology. 2006; 67(5):843-7. DOI: 10.1212/01.wnl.0000234037.91185.99. View

van der Flier W, Skoog I, Schneider J, Pantoni L, Mok V, Chen C . Vascular cognitive impairment. Nat Rev Dis Primers. 2018; 4:18003. DOI: 10.1038/nrdp.2018.3. View

Reed B, Villeneuve S, Mack W, DeCarli C, Chui H, Jagust W . Associations between serum cholesterol levels and cerebral amyloidosis. JAMA Neurol. 2014; 71(2):195-200. PMC: 4083819. DOI: 10.1001/jamaneurol.2013.5390. View

10.

Robertson D, Savva G, Kenny R . Frailty and cognitive impairment--a review of the evidence and causal mechanisms. Ageing Res Rev. 2013; 12(4):840-51. DOI: 10.1016/j.arr.2013.06.004. View

11.

Kwon H, Kim B, Lee S, Choi S, Oh B, Yoon B . Metabolic syndrome as an independent risk factor of silent brain infarction in healthy people. Stroke. 2005; 37(2):466-70. DOI: 10.1161/01.STR.0000199081.17935.81. View

12.

Roberts R, Knopman D . Classification and epidemiology of MCI. Clin Geriatr Med. 2013; 29(4):753-72. PMC: 3821397. DOI: 10.1016/j.cger.2013.07.003. View

13.

Prins N, van Dijk E, den Heijer T, Vermeer S, Koudstaal P, Oudkerk M . Cerebral white matter lesions and the risk of dementia. Arch Neurol. 2004; 61(10):1531-4. DOI: 10.1001/archneur.61.10.1531. View

14.

Gorelick P, Scuteri A, Black S, DeCarli C, Greenberg S, Iadecola C . Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association. Stroke. 2011; 42(9):2672-713. PMC: 3778669. DOI: 10.1161/STR.0b013e3182299496. View

15.

Burgess B, McIsaac S, Naus K, Chan J, Tansley G, Yang J . Elevated plasma triglyceride levels precede amyloid deposition in Alzheimer's disease mouse models with abundant A beta in plasma. Neurobiol Dis. 2006; 24(1):114-27. DOI: 10.1016/j.nbd.2006.06.007. View

16.

Choi H, Byun M, Yi D, Choe Y, Sohn B, Baek H . Association Between Serum Triglycerides and Cerebral Amyloidosis in Cognitively Normal Elderly. Am J Geriatr Psychiatry. 2016; 24(8):604-612. DOI: 10.1016/j.jagp.2016.03.001. View

17.

Jack Jr C, Bennett D, Blennow K, Carrillo M, Dunn B, Budd Haeberlein S . NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease. Alzheimers Dement. 2018; 14(4):535-562. PMC: 5958625. DOI: 10.1016/j.jalz.2018.02.018. View

18.

Katz M, Lipton R, Hall C, Zimmerman M, Sanders A, Verghese J . Age-specific and sex-specific prevalence and incidence of mild cognitive impairment, dementia, and Alzheimer dementia in blacks and whites: a report from the Einstein Aging Study. Alzheimer Dis Assoc Disord. 2011; 26(4):335-43. PMC: 3334445. DOI: 10.1097/WAD.0b013e31823dbcfc. View

19.

van Exel E, de Craen A, Gussekloo J, Houx P, Bootsma-van der Wiel A, Macfarlane P . Association between high-density lipoprotein and cognitive impairment in the oldest old. Ann Neurol. 2002; 51(6):716-21. DOI: 10.1002/ana.10220. View

20.

Takechi R, Galloway S, Pallebage-Gamarallage M, Mamo J . Chylomicron amyloid-beta in the aetiology of Alzheimer's disease. Atheroscler Suppl. 2008; 9(2):19-25. DOI: 10.1016/j.atherosclerosissup.2008.05.010. View